News centre | United Kingdom

Jul 20, 2020

Rutherford and Philips agree 10-year partnership to improve diagnostic services and patient outcomes across England


  • Rutherford Diagnostics and Philips announce partnership to utilise innovative technology to increase access to diagnostic services with five new community sites across England
  • Rutherford Health has entered into a contract with Somerset NHS Foundation Trust to provide diagnostic services via a new state-of-the-art diagnostics facility
  • The Taunton centre is expected to welcome patients in 2021
Guildford, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA), a leading global health technology company, announced last year that it had signed a 10-year strategic partnership agreement with Rutherford Diagnostics. This collaboration will utilise Philips innovative radiology technology and Rutherford Diagnostics’ healthcare expertise to deliver and operate advanced personalised diagnostic services through a network of community diagnostic centres, driving the best possible healthcare outcomes for patients. Rutherford Diagnostics is a subsidiary of Rutherford Health plc which operates a network of cancer centres across the United Kingdom.

The agreement has a term of 10-years and the two organisations will work in partnership to deliver advanced diagnostics services, through five new diagnostics centres across the UK. Under the terms of the agreement, which is built around a Managed Technology Service, Philips will deliver: state-of-the-art imaging equipment provision; management and technology utilisation reporting; continuous training; and a research and innovation program.


The impact of the COVID-19 pandemic has increased delays to cancer diagnosis and treatment in the United Kingdom.  According to recent research, concerns around access to routine screenings, urgent referrals and treatments could lead to a potential 7,000 excess deaths – rising to a worst-case scenario of 35,000¹.  Diagnostic centres such as Taunton will help support NHS capacity and expedite care of patients, improving efficiencies and patient experience. In addition to providing services to NHS patients, the centre will be available to private medical insurance and self-pay patients in the South West.


“For Philips, a successful partnership approach uses technology as an enabler to drive sustainable and improved clinical practices, patient outcomes and experience through innovation.” said Stephen McMillan, Solutions Lead for Philips in the UK and Ireland. “The current pandemic response has exacerbated the continuing challenges around how to ensure prompt access to healthcare as demand increases. Community Diagnostic Centres (CDC) and Community Diagnostic Training Centres (CDTC) have the ability to transform the current model of care delivery by providing access to ‘right first time’ diagnostic and treatment services closer to patient settings. Philips is proud to partner with Rutherford and looks forward to supporting the opening of their Taunton centre.”


“Our focus is to change the current healthcare paradigm from a reactive model which responds to disease, to one that is proactive and preventative with far reaching long-term benefits,” said Dr Steven Powell, Chief Diagnostic Officer of Rutherford Diagnostics. “We required a strategic partner who will complement our diagnostic service offering with technological innovation. Philips is closely aligned to our vision and can manage complexity while remaining flexible and is the right partner to support us on this journey.”


Philips and Rutherford Diagnostics will help expand access to diagnostic services for local patients in a cost-effective way that supports the best possible patient outcomes and experiences.


For more information on Philips Managed Services and Strategic Partnerships, please visit: http://philipsmanagedservices



Last accessed 13/07/20”

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company, focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnosis imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated in 2016 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News from Philips is located at

Click here to read moreClick here to read less

About Rutherford Health plc

Rutherford Health plc is at the vanguard of advancing cancer care. Developing and building a network of oncology centres across the UK known as the Rutherford Cancer Centres, offering a comprehensive range of cancer treatments to patients.

The first centre in Newport, South Wales, was the first in the UK to offer high energy proton therapy. In addition, each centre also offers radiotherapy, chemotherapy, immunotherapy, diagnostic imaging and supportive care services.

As well as the Rutherford Cancer Centre South Wales, Rutherford Health plc (formerly known as Proton Partners International Limited) has opened two further centres – the Rutherford Cancer Centre North East in Northumberland and the Rutherford Cancer Centre Thames Valley in Reading, with proton therapy now available in both. Construction of a fourth site in Liverpool, the Rutherford Cancer Centre North West, is due to open summer 2020.

Rutherford Health plc has partnered with world-leading healthcare technology providers to equip each centre with the very latest and innovative technology, including IBA, Philips and Elekta.

Rutherford Health plc was founded in 2015 by Mike Moran MBE and UK and international cancer experts, including Professor Edward Karol Sikora, former head of the World Health Organisation’s cancer programme.

Click here to read moreClick here to read less

About Rutherford Diagnostics

Rutherford Diagnostics Ltd, was established as a subsidiary of Rutherford Health plc to develop a network of advanced diagnostic centres across the UK to meet increasing demand for faster diagnosis. In addition, to providing services to NHS patients, Rutherford Diagnostics’ Centres and services will be available to private medical insurance and self-paying patients.

Click here to read moreClick here to read less

For further information, please contact:

Emily Wells- Burr

Integrated Communications Manager, Philips UKI

Tel: 07825 105 685




Emily Wells Burr

Emily Wells- Burr

Integrated Communications Manager, Personal Health

Tel: + 44 (0) 7825 105 685

Media assets

Share on social media